Skip to main content
Premium Trial:

Request an Annual Quote

Akoya Biosciences Inks Comarketing Deal for Tissue Imaging Tech With Zeiss

NEW YORK — Akoya Biosciences said on Monday that it has signed a comarketing agreement with German optics firm Zeiss for Akoya's co-detection by indexing, or CODEX, spatial phenotyping system and a Zeiss microscope.

CODEX enables multiplexed imaging of 40 or more protein markers at single-cell resolution in tissue samples. Under the terms of the deal, the system will be comarketed and integrated with Zeiss' Axio Observer microscope platform.

The firms said the partnership will lead to enhanced workflows, faster acquisition speeds, and potential future collaborations and that integrating the two systems will advance applications in cancer, immunology, developmental biology, neurology, and other areas.

"The scientific community will benefit from improved integration of the two systems and the resulting intuitive path to decoding the complexities of spatial tissue biology," Bernhard Zimmermann, head of business sector life sciences at Jena-based Zeiss Research Microscopy Solutions, said in a statement. "We are especially excited about the potential of spatial omics being taken to the next level by expanding into advanced imaging modalities, including Zeiss Airyscan and Zeiss Elyra super-resolution technology."

Additional terms were not disclosed.

Earlier this year, Marlborough, Massachusetts-based Akoya began offering the CODEX technology to members of the Human Cell Atlas consortium.